OpenAlex
PricingAboutJobs
Log inGet started
Work

Improved outcome of N-butyldeoxygalactonojirimycin-mediated substrate reduction therapy in a mouse model of Sandhoff disease

HTML

Year: 2004
Type: article
Source: Neurobiology of Disease
DOI: 10.1016/j.nbd.2004.04.012
Authors: Ulrika Andersson, David Smith, Mylvaganam Jeyakumar, Terry D Butters, Mario Cortina Borja, Raymond A Dwek, Frances M Platt
Institutions: University of Oxford, University College London
Language: English

Topic: Lysosomal Storage Disorders Research
Subfield: Genetics (clinical)
Field: Medicine
Domain: Health Sciences
Keywords: Sandhoff disease, substrate reduction therapy, N-butyldeoxynojirimycin, glycosphingolipid biosynthesis, lysosomal storage disease, gangliosidoses, mouse model, dose escalation, neurodegeneration
SDG: Good health and well-being

Open Access status: green

Funders: Wellcome Trust, Lister Institute of Preventive Medicine, National Institutes of Health, Biotechnology and Biological Sciences Research Council
OpenAlex ID: W2083102048
FWCI: 4.851
Cites: 22
Cited by: 84
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security